RoundTable Healthcare Partners has announced it has completed the sale of Symmetry Surgical to Aspen Surgical Products.

Symmetry Surgical, based in Antioch, Tenn., is a marketer of reusable, reposable and single-use surgical instrumentation and specialty devices. Founded in 2012, the company’s brands include Bookwalter, Bovie, Greenberg, Reddick and The O.R. Company.

RoundTable, based in Lake Forest, Ill., is an operating-oriented private equity firm focused exclusively on the healthcare industry. Founded in 2001, the firm targets middle market investments in medical devices, medical products and disposables; specialty pharmaceuticals; medication delivery systems; specialty distribution; and complementary outsourced services.

RoundTable acquired a majority interest in Symmetry in July 2016.

Aspen, established in 1999 and based in Caledonia, Mich., is manufacturer of surgical disposables and portfolio company of Audax Private Equity.

Audax, with private equity offices in Boston, New York and San Francisco, focuses on investments in middle market companies and has a wide flexibility on investment size. Founded in 1999, the firm targets companies within healthcare and several other industries, specifically those generating between $10 million and $50 million in annual EBITDA.

Terms of the transaction were not disclosed.

New Mountain Capital has announced an investment in ClaimLogiq.

ClaimLogiq, founded in 2013 and based in Mount Pleasant, S.C., is the developer of TrueCost, a payer-facing, claim-analyzing solution.

New Mountain, based in New York, is a growth-oriented investment firm. Founded in 1999, the firm manages private equity, credit and net lease real estate funds with more than $37 billion in assets under management.

Terms of the investment were not disclosed.

Signet Healthcare Partners has completed a growth capital investment in LAXAI, according to a news release.

LAXAI, with U.S. offices in Massachusetts and California, is an integrated contract research, development and manufacturing organization. Founded in 2007, the company’s solutions include drug discovery, chemical process research and development and manufacturing for pharmaceutical, biotech and specialty chemicals companies located throughout the world.

Signet, based in New York and founded in 1998, is a private equity fund that focuses on investments in commercial-stage healthcare companies, specifically pharmaceutical sector and medical technology companies.

Terms of the investment were not disclosed.

Bain Capital Private Equity has invested in CitiusTech, according to a news release.

CitiusTech, based in Princeton, N.J., is a provider of digital technology and consulting services to payer, provider, medical technology and life sciences companies. Founded in 2005, the company’s key focus areas include healthcare interoperability, data management, quality and performance analytics, value-based care, patient experience, medical imaging, connected health, payer-provider convergence, care coordination and population health management.

Bain Capital Private Equity, based in Boston, focuses on making control and minority equity investments and prefers to make more substantial investments from a dollars perspective. Founded in 1984, the firm invests in healthcare and several other industries, targeting companies with revenue of at least $100 million. Within healthcare, Bain Capital Private Equity targets companies in the provider services, hospital/major facilities, life sciences/pharmaceutical and non-reimbursement industries.

Terms of the investment were not disclosed.

Cimarron Healthcare Capital and Tacoma Holdings have announced the recapitalization of Frontpoint Health.

Frontpoint is a home health and hospice platform focused primarily on servicing Medicare Advantage patients in the Texas market.

Cimarron, based in Salt Lake City, is a healthcare-focused private equity firm targeting investments in the lower middle market. Founded in 2015, the firm typically invests between $10 million and $30 million per transaction.

Tacoma, based in Park City, Utah, is a private equity firm focused on investments in the lower middle market. Founded in 2020, the firm typically invests between $10 million and $50 million in healthcare services and companies in other sectors.

Terms of the recap were not disclosed.

Veritas Capital has announced the closing of its latest fund, Veritas Capital Fund VIII, with $10.65 billion.

The fund was oversubscribed and exceeded its hard cap of $8.5 billion.

Veritas, based in New York, is a private equity firm that primarily targets technology or technology-enabled solutions for several sectors, including healthcare.

NovaQuest Private Equity (NQPE) has invested in Bend Bioscience, according to a news release.

Bend Bioscience, based in Bend, Ore., is an early-phase contract development and manufacturing organization (CDMO). Founded in 2021, the company specializes in particle engineering, drug delivery, drug development and manufacturing to the pharmaceutical industry.

NQPE is a private equity firm that invests in lower middle market healthcare services and technology companies primarily in North America. It’s the private equity group of NovaQuest Capital Management, which is based in Raleigh, N.C., and was formed in 2000.

As a result of the investment, the Bend Bioscience team is now part of CDMO CoreRx.

Terms of the investment were not disclosed.

TPG Capital has completed its acquisition of ClaimsXten, Change Healthcare’s claims editing business, from UnitedHealth for $2.2 billion, according to news reports.

The sale of ClaimsXten follows UnitedHealth’s acquisition of Change Healthcare. This transaction was placed on hold after the U.S. Department of Justice sued to stop it. Last month, a federal judge ruled UnitedHealth’s acquisition could proceed.

TPG Capital, headquartered in Fort Worth, Texas and San Francisco, targets investments in middle-market companies in healthcare and a number of other industries.

The Vistria Group has announced it has invested in Flores & Associates.

Flores, based in Charlotte, N.C., is a provider of benefit technology solutions and administrative services to employers throughout the United States. Founded in 1986, the company is an administrator of employer-sponsored reimbursement plans, including flexible spending accounts, health savings accounts and health reimbursement accounts and other types of accounts.

The Vistria Group, based in Chicago, focuses on making investments in middle market companies in healthcare and a few other industries. Founded in 2013, the firm pursues control and minority equity investments and prefers to make more substantial investments from a dollars perspective in companies with at least $100 million in revenue.

As part of the transaction, The Vistria Group and Century Equity Partners will each hold equal ownership

Century, based in Boston and founded in 1987, focuses exclusively on making private equity investments in lower middle market financial services companies. 

Terms of the investment were not disclosed.

HCAP Partners has announced it and Baymark Partners have invested in DFW Neuropathy.

DFW Neuropathy, based in North Texas, is a neuropathy treatment company. Founded in 2010, the company specializes in combination electroanalgesia treatment intended to heal or reverse peripheral neuropathy.

HCAP Partners, based in San Diego, is a private equity firm that provides growth capital to lower middle market companies throughout California and the Western United States. Founded in 2000, the firm seeks to invest $2 million to $15 million in businesses generating between $10 million and $100 million in revenues in healthcare and a few other industries.

Baymark, which led the transaction, is a Dallas-based private equity firm. Founded in 2009, the firm targets middle market service (healthcare, business and IT), distribution, manufacturing and tech-enabled (SaaS and e-commerce) companies with EBITDA of $2 million to $20 million.

Terms of the investment were not disclosed.